FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diclofenac Sodium (Dyloject) Injection
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

Hospira, Inc. (New 11/14/2017)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
Dyloject™ (Diclofenac Sodium) Injection 37.5 mg/mL Single Dose Glass Fliptop Vial (NDC 0409-1068-01) 11/14/2017 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English